Protalix Biotherapeutics Inc. buy melinda
Start price
17.05.17
/
50%
€7.24
Target price
25.05.17
€9.00
Performance (%)
12.85%
End price
25.05.17
€8.17
Summary
This prediction ended on 25.05.17 with a price of €8.17. The BUY prediction by melinda finished with a performance of 12.85%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 3.951% | 3.951% | 68.400% | 32.307% |
| iShares Core DAX® | -3,17 % | 1,23 % | 2,54 % | 51,99 % |
| iShares Nasdaq 100 | -1,01 % | 0,38 % | 32,25 % | 87,19 % |
| iShares Nikkei 225® | -3,60 % | 1,00 % | 59,53 % | 72,47 % |
| iShares S&P 500 | 0,21 % | 2,92 % | 24,52 % | 69,84 % |
According to melinda what are the pros and cons of Protalix Biotherapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
Gesundheit | Biotechnologie | Israel
Stopped prediction by melinda for Protalix Biotherapeutics Inc.
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.56
28.12.25
28.12.25
-
28.12.26
28.12.26
-1.28%
03.01.26
03.01.26
Could be worthwhile Investment >10% per year
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
27.12.23
27.12.23
€2.00
27.12.24
27.12.24
9.02%
28.12.24
28.12.24
Could be worthwhile Investment >10% per year
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.96
02.06.16
02.06.16
€12.00
02.12.16
02.12.16
-22.13%
02.12.16
02.12.16
Could be worthwhile Investment >10% per year
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€32.52
23.09.13
23.09.13
€40.00
24.03.14
24.03.14
2.15%
24.03.14
24.03.14
Could be worthwhile Investment >10% per year